A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin Levels
| Autor: | Gérard Waeber, Robert Sladek, Nicholas J. Timpson, Luigi Ferrucci, James B. Meigs, David M. Evans, Marie-France Hivert, George Davey Smith, John E. Deanfield, J. Brent Richards, Joseph M. Devaney, Beate Glaser, Toshiko Tanaka, Ruth J. F. Loos, Claudia Langenberg, Christina Willenborg, Christian Hengstenberg, Stephen O'Rahilly, Peter Vollenweider, Klaus Stark, John R. B. Perry, Jaquelin C. M. Witteman, Vincent Mooser, Ruth McPherson, Sally L. Ricketts, Nuno Rocha, Naveed Sattar, Muredach P. Reilly, Scott M. Grundy, Elin Grundberg, Alexandre F.R. Stewart, Keith Burling, Janina Winogradow, Robert K. Semple, Nicole Soranzo, Stephen E. Epstein, Martina Grassl, Mary-Susan Burnett, Robert W. Mahley, John R. Thompson, Nicholas J. Wareham, Josée Dupuis, David Melzer, Richa Saxena, Yurii S. Aulchenko, Panos Deloukas, Josephine M. Egan, Jose C. Florez, H-Erich Wichmann, Wibke Reinhard, Tim D. Spector, Dawn M. Waterworth, Daniel J. Rader, Cornelia M. van Duijn, Nilesh J. Samani, Inke R. König, Inga Prokopenko, Aroon D. Hingorani, Tomi Pastinen, Timothy M. Frayling, Heribert Schunkert, Y. Antero Kesäniemi, Phil Barter, Kijoung Song, Jeanette Erdmann, Alistair S. Hall |
|---|---|
| Přispěvatelé: | Ophthalmology, Epidemiology, Song Kijoung) |
| Rok vydání: | 2009 |
| Předmět: |
Male
Cancer Research medicine.medical_specialty European community lcsh:QH426-470 Study research 030209 endocrinology & metabolism Coronary Disease Biology Polymorphism Single Nucleotide German Diabetes and Endocrinology/Obesity 03 medical and health sciences 0302 clinical medicine Framingham Heart Study SDG 3 - Good Health and Well-being Genetics medicine GIANT Consortium Humans Genetic Predisposition to Disease Cardiovascular Disorders/Congenital Heart Disease Diabetes and Endocrinology/Type 2 Diabetes General hospital Molecular Biology Genetics (clinical) Ecology Evolution Behavior and Systematics Genetics and Genomics/Genetics of Disease 030304 developmental biology 0303 health sciences 0604 Genetics Molecular-Weight Adiponectin Bone-Mineral Density Small G-Proteins Insulin-Resistance Plasma Adiponectin Metabolic Syndrome Circulating Adiponectin Myocardial-Infarction Serum Concentration APM1 Gene Colaus Study nutritional and metabolic diseases medicine.disease Medical research Obesity language.human_language lcsh:Genetics Diabetes Mellitus Type 2 Research centre Family medicine language Female Adiponectin Developmental Biology Genome-Wide Association Study Research Article |
| Zdroj: | PLoS Genetics (print), 5(12). Public Library of Science Scopus-Elsevier PLoS Genetics, Vol 5, Iss 12, p e1000768 (2009) PLoS Genetics PLoS genetics PLoS Genetics, vol. 5, no. 12, pp. 1000768 e1000768 PLoS Genetics; Vol 5 |
| ISSN: | 1553-7390 |
| Popis: | The adipocyte-derived protein adiponectin is highly heritable and inversely associated with risk of type 2 diabetes mellitus (T2D) and coronary heart disease (CHD). We meta-analyzed 3 genome-wide association studies for circulating adiponectin levels (n = 8,531) and sought validation of the lead single nucleotide polymorphisms (SNPs) in 5 additional cohorts (n = 6,202). Five SNPs were genome-wide significant in their relationship with adiponectin (P≤5×10−8). We then tested whether these 5 SNPs were associated with risk of T2D and CHD using a Bonferroni-corrected threshold of P≤0.011 to declare statistical significance for these disease associations. SNPs at the adiponectin-encoding ADIPOQ locus demonstrated the strongest associations with adiponectin levels (P-combined = 9.2×10−19 for lead SNP, rs266717, n = 14,733). A novel variant in the ARL15 (ADP-ribosylation factor-like 15) gene was associated with lower circulating levels of adiponectin (rs4311394-G, P-combined = 2.9×10−8, n = 14,733). This same risk allele at ARL15 was also associated with a higher risk of CHD (odds ratio [OR] = 1.12, P = 8.5×10−6, n = 22,421) more nominally, an increased risk of T2D (OR = 1.11, P = 3.2×10−3, n = 10,128), and several metabolic traits. Expression studies in humans indicated that ARL15 is well-expressed in skeletal muscle. These findings identify a novel protein, ARL15, which influences circulating adiponectin levels and may impact upon CHD risk. Author Summary Through a meta-analysis of genome-wide association studies of 14,733 individuals, we identified common base-pair variants in the genome which influence circulating adiponectin levels. Since adiponectin is an adipocyte-derived circulating protein which has been inversely associated with risk of obesity-related diseases such as type 2 diabetes (T2D) and coronary heart disease (CHD), we next sought to understand if the identified variants influencing adiponectin levels also influence risk of T2D, CHD, and several metabolic traits. In addition to confirming that variation at the ADIPOQ locus influences adiponectin levels, our analyses point to a variant in the ARL15 (ADP-ribosylation factor-like 15) locus which decreases adiponectin levels and increases risk of CHD and T2D. Further, this same variant was associated with increased fasting insulin levels and glycated hemoglobin. While the function of ARL15 is not known, we provide insight into the tissue specificity of ARL15 expression. These results thus provide novel insights into the physiology of the adiponectin pathway and obesity-related diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|